At PGXIS, we use our expertise in pharmacogenomics together with the power of modern genetics to:
- Enhance the efficiency of drug development, making more medicines available to meet the needs of patients
- Increase the clinical effectiveness of medicines so that patients taking the medicines receive maximum benefit
|
To do this, we have two parts to our business:
1) Consultancy, working with pharmaceutical and biotechnology companies to improve the development pipelines and cost-effectiveness of medicines
2) Partnering with drug discovery organisations to build our own portfolio through co-development or in-licensing
|
|
